Heather Shah, M.D.
Oncology / Clinical Investigator
Facility/Office:Oncology Specialties, P.C.
Clearview Cancer Institute
3601 CCI Drive Huntsville, Alabama 35805
One Hospital Drive
Huntsville, AL 35801
Phone (256) 713-1200
107 Avenue SE Plaza II
Decatur, AL 35601
Education:Auburn University, B.S. Bi medical Services, 1999
University of Alabama, Medical Doctor (M.D.), 2003
Internship:University of Alabama, Internal Medicine Internship, 7/2003 to 6/2004
University of Alabama, Internal Medicine Internship, 7/2004 to 6/2007
Fellowship:University of Alabama Hematology/Oncology, 7/2007 to 6/2010
Certification:American Board of Internal Medicine, 2006
American Board of Medical Oncology, 2010
American Board of Hematology, 2011
More/Other Information:HOSPITAL AFFILIATIONS
Huntsville Hospital in Huntsville, AL
Decatur Morgan Hospital in Decatur, AL
Crestwood Medical Center in Huntsville, AL
Lawrence Medical Center in Moulton, AL
American Medical Association
American College of Physicians
American Society for Blood and Marrow Transplantation. Associate Member American Society of Clinical Oncology, Active Allied Member
American Society of Hematology, Associate Member
American Society of Clinical Oncology, Associate Member
American Association for Cancer Research, Associate Member
2009 Chapter 25: Investigational Molecular Prognostic Factors for Breast Carcinoma. The Breast: Comprehensive Management of Benign and Malignant Diseases 4th Edition, 2009, by K. Bland, E. Copeland III. Cowritten with Dr. L. Nabell.
2009 Predicting sensitivity of pancreatic and colorectal cancers to EGF-R inhibition. Hematology/Oncology Fellows' Research Presentations. January 2009.
2008 Diagnostic testing in carcinoma of unknown primary. University of Alabama at Birmingham Division of Hematology/Oncology Gran Rounds. November 2008.
2008 Disseminated intravascular coagulation University of Alabama at Birmingham Division of Hematology/Oncology Grand Rounds. April 2008
2007 Successful full-term birth in an allogeneic stem cell transplant patient with active extensive chronic graft-versus-host disease. H. S ah, D. Salzman, K. Ashraf, and W. Vaughan. 110:5016. Blood (ASH Meeting Abstracts), Nov. 2007.
2007 Use of a single red cell exchange to treat sickle cell intrahepatic cholestasis. Y.A. Park, H. Shah, L.N. Council, S.T. Huang. Transfusion 07:47 (3S):54A.
2006 Author, Question Development, ACP Medicine Chapter self-assessment program.
2006 A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin. H. Shah, L. Ledbetter, R. Diaiso, M.W. Saif. Clinical Colorectal Cancer, 2006 Jan 5(5): 354B
2005 Retrospective analysis of coagulation abnormalities in patients receiving capecitabine (CAP) and warfarin (WAR). H. Shah and M.W. Sa , UAB. Poster presented at annual ASCO meeting on May 15, 2005.
2005 Reduction in serum myeloma (M) paraprotein after cyclophosphamide (CY) mobilization predicts for improved survival after single agent melphalan (M) based autologous hematopoetic stem cell transplant (AHSCT). Charu Aggarwal, BBS, Heather Shah, M.D., Donna Salzman, M.D., Arabella Tilden, Ph.D., and William Vaughan, M.D. Poster presented at annual ASBMT meeting on February 13, 2005.